These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine. de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793 [TBL] [Abstract][Full Text] [Related]
3. American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity. Desmarais J; Rosenbaum JT; Costenbader KH; Ginzler EM; Fett N; Goodman S; O'Dell J; Pineau CA; Schmajuk G; Werth VP; Link MS; Kovacs R Arthritis Rheumatol; 2021 Dec; 73(12):2151-2160. PubMed ID: 34697918 [TBL] [Abstract][Full Text] [Related]
4. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study. Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports. Goldman A; Bomze D; Dankner R; Hod H; Meirson T; Boursi B; Maor E Br J Clin Pharmacol; 2021 Mar; 87(3):1432-1442. PubMed ID: 32964535 [TBL] [Abstract][Full Text] [Related]
6. Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions. Souza Botelho M; Bolfi F; Leite RGOF; Leite MSF; Banzato LR; Soares LT; Olivatti TOF; Mangolim AS; Oliveira FRK; Abbade LPF; Abbade JF; de Barros Almeida RAM; Simões Corrêa Galendi J; Thabane L; Dos Santos Nunes-Nogueira V Syst Rev; 2021 Nov; 10(1):294. PubMed ID: 34736537 [TBL] [Abstract][Full Text] [Related]
7. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Shah S; Das S; Jain A; Misra DP; Negi VS Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of ECG testing and characteristics among new hydroxychloroquine and chloroquine users within a multi-center tertiary care center. Choi MY; Weber B; Stevens E; Guan H; Ellrodt J; Oakes E; Di Carli M; Tedrow U; Sauer W; Costenbader KH Rheumatol Int; 2022 Oct; 42(10):1767-1774. PubMed ID: 35430712 [TBL] [Abstract][Full Text] [Related]
9. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story. Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285 [TBL] [Abstract][Full Text] [Related]
10. An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy. Celotto S; Veronese N; Barbagallo M; Ometto F; Smith L; Pardhan S; Barnett Y; Ilie PC; Soysal P; Lagolio E; Kurotschka PK; Tonelli R; Demurtas J Int J Infect Dis; 2021 Feb; 103():599-606. PubMed ID: 33316389 [TBL] [Abstract][Full Text] [Related]
11. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review. Nadeem U; Raafey M; Kim G; Treger J; Pytel P; N Husain A; Schulte JJ Am J Clin Pathol; 2021 May; 155(6):793-801. PubMed ID: 33316045 [TBL] [Abstract][Full Text] [Related]
12. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis. Elavarasi A; Prasad M; Seth T; Sahoo RK; Madan K; Nischal N; Soneja M; Sharma A; Maulik SK; Shalimar ; Garg P J Gen Intern Med; 2020 Nov; 35(11):3308-3314. PubMed ID: 32885373 [TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388 [TBL] [Abstract][Full Text] [Related]
14. Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure. Kapuy O; Korcsmáros T PLoS One; 2022; 17(4):e0266337. PubMed ID: 35390060 [TBL] [Abstract][Full Text] [Related]
15. Chloroquine and hydroxychloroquine for COVID-19: Perspectives on their failure in repurposing. Shah RR J Clin Pharm Ther; 2021 Feb; 46(1):17-27. PubMed ID: 32981089 [TBL] [Abstract][Full Text] [Related]
16. Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine. Sarayani A; Cicali B; Henriksen CH; Brown JD Res Social Adm Pharm; 2021 Feb; 17(2):483-486. PubMed ID: 32327397 [TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak. Nicolò M; Ferro Desideri L; Bassetti M; Traverso CE Int Ophthalmol; 2021 Feb; 41(2):719-725. PubMed ID: 32946004 [TBL] [Abstract][Full Text] [Related]
18. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review. Rodrigo C; Fernando SD; Rajapakse S Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568 [TBL] [Abstract][Full Text] [Related]
19. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19? Derwand R; Scholz M Med Hypotheses; 2020 Sep; 142():109815. PubMed ID: 32408070 [TBL] [Abstract][Full Text] [Related]
20. Vinpocetine protects against chloroquine-induced cardiotoxicity by mitigating oxidative stress. Abdelmageed N; Twafik WA; Morad OA; Haridy M; Hassan R; Ahmed M; El-Zorba HY; El-Banna HA; Seddek AL; Ghallab A; Morad SAF Arch Toxicol; 2023 Oct; 97(10):2763-2770. PubMed ID: 37401952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]